SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
Conditions
- Urologic Cancer
- Biochemical Recurrence of Malignant Neoplasm of Prostate
Interventions
- DRUG: Pembrolizumab Injection [Keytruda]
- RADIATION: Salvage Radiation Therapy (SRT)
Sponsor
Prof. Dr. med. Christian Gratzke
Collaborators